Corrigendum to “Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch” [Redox Biol. 52 (2022) 1–16/102311]

After publication of the original article [1], it came to the authors' attention that one important piece of information was lost for affiliation “b Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, China”. It should be “b Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China”. The affiliations are correct in this corrigendum.